Pharmacogenomics and dermatological therapeutics

Archives of Dermatology

Volumn 137, Issue 11, 2001, Pages 1512-1514

  Lowitt, Mark H ^a   Shear, Neil H ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CLOTRIMAZOLE; CODEINE; CYTOCHROME P450; EPOXIDE HYDROLASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HYDRALAZINE; IMIPRAMINE; KETOCONAZOLE; LORATADINE; METHOXSALEN; ONDANSETRON; PERPHENAZINE; PRIMAQUINE; PROCAINAMIDE; SALAZOSULFAPYRIDINE; THIOPURINE METHYLTRANSFERASE; UROPORPHYRINOGEN DECARBOXYLASE;

BONE MARROW SUPPRESSION; DRUG ACETYLATION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; ENZYME DEFICIENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYTIC ANEMIA; HUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; SHORT SURVEY; WILSON DISEASE;

EID: 0035174810     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.137.11.1512     Document Type: Short Survey

References (12)

1. Pharmacogenetics and cutaneous drug reactions
2. Pharmacogenetics and adverse drug reactions in the skin
3. Advances in pharmacogenetics and pharmacogenomics
4. Pharmacogenetics
5. Pharmacogenetic and biologic markers of unintended drug effects
6. A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome
7. Anticonvulsant hypersensitivity syndrome
8. Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant drug reactions
9. Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome
10. N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus
11. Pharmacogenomics and the changing face of clinical pharmacology
12. Pharmacogenetics, pharmacogenomics, and pharmacobiology